Answers are grounded in this paper and cite their sources.
Type 2 diabetes mellitus (T2DM) is a prevalent chronic condition with increasing global incidence, necessitating effective and well-tolerated treatment options. In recent years, the combination of lobeglitazone sulfate and glimepiride has emerged as a promising therapeutic approach. Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are already treated with a thiazolidinedione and sulphonylurea or who have inadequate glycemic control on a thiazolidinedione alone or a sulphonylurea alone. This review aims to comprehensively evaluate the efficacy and safety of lobeglitazone sulfate + glimepiride tablets in the management of T2DM.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: